HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment
December 22, 2023
New York, December 22, 2023 – Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of